Sodium-glucose cotransporter-2 inhibitors: where and when?

被引：1
|
作者：
Cowie, Martin R. [1 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, Royal Brompton Hosp, London, England
来源：
FUTURE CARDIOLOGY | 2020年 / 17卷 / 03期
关键词：
cardiovascular disease; chronic kidney disease; diabetes mellitus; guidelines; heart failure; implementation; outcome trials; SGLT2; inhibitors; REDUCED EJECTION FRACTION; HEART-FAILURE;
D O I：
10.2217/fca-2020-0207
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Tweetable abstract Sodium-glucose cotransporter-2 inhibitors not only improve glycaemic control in Type 2 diabetes mellitus but convincingly improve outcome for everyone with HFrEF and albuminuric kidney disease. Trials then license - now all we need is implementation
引用
收藏
页码：403 / 406
页数：4
相关论文
共 50 条
  • [1] Sodium-Glucose Cotransporter-2 Inhibitors in Depression
    Liebers, David T.
    Ebina, Wataru
    Iosifescu, Dan V.
    HARVARD REVIEW OF PSYCHIATRY, 2023, 31 (04) : 214 - 221
  • [2] Gout and sodium-glucose cotransporter-2 inhibitors
    Lai, Shih-Wei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (01) : 112 - 113
  • [3] Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis
    Anan, Go
    Kikuchi, Daisuke
    Hirose, Takuo
    Ito, Hiroki
    Nakayama, Shingo
    Mori, Takefumi
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (04): : 925 - 928
  • [4] Erythrocytosis induced by sodium-glucose cotransporter-2 inhibitors
    Chin-Yee, Benjamin
    Solh, Ziad
    Hsia, Cyrus
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (42) : E1271 - E1271
  • [5] Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
    Heerspink, Hiddo J. L.
    Kosiborod, Mikhail
    Inzucchi, Silvio E.
    Cherney, David Z. I.
    KIDNEY INTERNATIONAL, 2018, 94 (01) : 26 - 39
  • [6] RE: Gout and sodium-glucose cotransporter-2 inhibitors
    Lund, Lars Christian
    Hojlund, Mikkel
    Henriksen, Daniel Pilsgaard
    Hallas, Jesper
    Kristensen, Kasper Bruun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (01) : 114 - 115
  • [7] Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature
    Mckenzie, Taylor
    Hale, Genevieve M.
    Miner, Amelia
    Colon, Jean Colon
    Evins, Garrett
    Wade, Jasmine
    HEART FAILURE REVIEWS, 2024, 29 (02) : 549 - 558
  • [8] Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature
    Taylor McKenzie
    Genevieve M. Hale
    Amelia Miner
    Jean Colón Colón
    Garrett Evins
    Jasmine Wade
    Heart Failure Reviews, 2024, 29 : 549 - 558
  • [9] Cardiovascular effects and mechanisms of sodium-glucose cotransporter-2 inhibitors
    Yang Fan
    Meng Ran
    Zhu Da-Long
    慢性疾病与转化医学(英文), 2020, 06 (04) : 239 - 245
  • [10] Expanding Clinical Use of Sodium-glucose Cotransporter-2 Inhibitors?
    Dhawan, Richa
    Chaney, Mark A.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2024, 38 (10) : 2135 - 2138
12345